Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
such that non-credible contingency event impacts can be assessed presents many challenges including: Redispatch of network to reflect future forecast of demand and generation Modelling of future network
-
known as Team COMPAS -- includes a number of amazing undergraduate and graduate students, postdocs, alumni, and other fantastic collaborators. Please contact me if you are interested in joining our group
-
theoretical colleagues. All research takes place within our dynamic particle physics research group with academics and postdocs, as well as graduate and undergraduate students. Some work will be purely
-
sky research’ to projects focused on commercialisation and policy. We have no defining theme but draw researchers from across disciplines. Our essential selection criteria are excellence, engagement and
-
qualitative research methodologies including research skills and some experience with the use of qualitative data software such as NVivo. The candidate: Must meet all Curtin University HDR enrolment
-
Vulnerability Detection of Smart Grids with a Specific Focus on Generative Adversarial Networks (GAN) Attacks Primary supervisors: Professor Damminda Alahakoon & Dr Shalinka Jayatilleke Other supervisors
-
will design quantum-safe threshold encryption and/or authentication algorithms. The expected outcome is the design of methods, techniques and their software prototype to implement quantum-safe threshold
-
assessed through a network of long-term trials across the pastoral, low, medium, and high rainfall zones of South Australia. Receive a $40,000 (2024 full-time rate) per annum scholarship tax free, for up
-
Currently recruiting students via universities around Australia Receive actual industry exposure and partner placements to develop your skills and network Encouraging students from all academic backgrounds
-
how to accurately predict IBD activity in pregnancy and subsequently any changes to the foetal/neonatal immune system and brain development. The study will define how thiopurine metabolite, vedolizumab